BioWorld Science

Aug. 21, 2019

View Archived Issues

Malaria vaccine has indirect protective effects

Read More

ActoBio Therapeutics announces IND approval for AG-017 for the treatment of celiac disease

Read More

Oral HRI activator EPB-53 improves glucose intolerance through FGF21

Read More

Experiments reveal the role of GDNF in intestinal epithelial barrier dysfunction in IBD

Read More

Study of RAC1 P29S mutation in melanoma points to target for reversing BRAF inhibitor resistance

Read More

Aerie initiates first-in-human study of AR-13503 sustained-release intravitreal Implant

Read More

First patient dosed in global phase II study of BT-11 in mild to moderate ulcerative colitis

Read More

Synlogic discontinues development of SYNB-1020 for the treatment of hyperammonemia

Read More

PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification

Read More

Novel mannosylated nanovaccines sensitize melanoma to immune checkpoint modulators

Read More

The other end of APP

Read More

Vertex Pharmaceuticals, Merck Patent disclose eIF-2-alpha kinase GCN2 inhibitors

Read More

More evidence links Schwann cells to pain

Read More

Sinovent discovers beta-lactamase inhibitors

Read More

Tau imagining agents patented by AC Immune, Life Molecular Imaging

Read More

Blastocyst-like embryonic structure grown from stem cells

Read More

ST Pharm presents new antivirals

Read More

New cyclin-dependent kinase 4/6 inhibitors identified at Beta Pharma

Read More

Phase III NEPTUNE study does not meet primary endpoint in patients with high TMB

Read More

Mersana Therapeutics initiates expansion portion of phase I trial of XMT-1536

Read More

First patient enrolled in observational study of children and adolescents with Dravet syndrome

Read More